Belgium makes biomedical sector pay for overspending
This article was originally published in Clinica
Clinical analyses and imaging are among the sectors listed as being responsible for the Belgian healthcare 2001 budget deficit. Spending on clinical analyses totalled BFr 2,705.6 million ($61.6 million), and on medical imaging, BFr 2,656.8 million. The two sectors will now have to redress this balance and suffer a cut in the amount the health insurance paid per procedure for 12 months, beginning on July 1 2002.
You may also be interested in...
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”
After almost a year as CEO of Centrient, Rex Clements reflects on the company’s experiences operating amid a pandemic that has underlined the importance of a diversified supply chain, while also highlighting the firm’s sustainable manufacturing initiatives and calling for non-price criteria to be taken into account by procurement processes, in an exclusive interview with Generics Bulletin.